{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:10:10Z","timestamp":1761300610780,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Association for Maternal and Child Health Studies","award":["JSFY202202"],"award-info":[{"award-number":["JSFY202202"]}]},{"name":"Traditional Chinese medicine clinical transformation of public service platform in Jiangsu province","award":["BM2023005"],"award-info":[{"award-number":["BM2023005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00995-z","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:06:25Z","timestamp":1761300385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultrasound stimulated microbubble cavitation promoted the anticancer effect of Lenvatinib on anaplastic thyroid cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Sujuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"204201882110546","DOI":"10.1177\/20420188211054692","volume":"12","author":"S Agosto Salgado","year":"2021","unstructured":"Agosto Salgado S. Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology. Ther Adv Endocrinol Metab. 2021;12:20420188211054692. https:\/\/doi.org\/10.1177\/20420188211054692.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"995_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje-20-0080","volume":"183","author":"M de Ridder","year":"2020","unstructured":"de Ridder M, van Nieveen E, Engelsman A, Kapiteijn E, Kl\u00fcmpen HJ, Rasch CRN. Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades. Eur J Endocrinol. 2020;183(2):203\u20139. https:\/\/doi.org\/10.1530\/eje-20-0080.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"995_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.5306\/wjco.v14.i12.570","volume":"14","author":"ET Pavlidis","year":"2023","unstructured":"Pavlidis ET, Galanis IN, Pavlidis TE. Update on current diagnosis and management of anaplastic thyroid carcinoma. World J Clin Oncol. 2023;14(12):570\u201383. https:\/\/doi.org\/10.5306\/wjco.v14.i12.570.","journal-title":"World J Clin Oncol"},{"key":"995_CR4","doi-asserted-by":"publisher","unstructured":"Yuan J, Guo Y. Targeted therapy for anaplastic thyroid carcinoma: advances and management. Cancers (Basel). 2022;15(1). https:\/\/doi.org\/10.3390\/cancers15010179.","DOI":"10.3390\/cancers15010179"},{"issue":"5","key":"995_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3892\/ijo.2019.4881","volume":"55","author":"S Ishihara","year":"2019","unstructured":"Ishihara S, Onoda N, Noda S, Asano Y, Tauchi Y, Morisaki T, Kashiwagi S, Takashima T, Ohira M. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status. Int J Oncol. 2019;55(5):1069\u201376. https:\/\/doi.org\/10.3892\/ijo.2019.4881.","journal-title":"Int J Oncol"},{"key":"995_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fonc.2017.00025","volume":"7","author":"M Tahara","year":"2017","unstructured":"Tahara M, Kiyota N, Yamazaki T, Chayahara N, Nakano K, Inagaki L, Toda K, Enokida T, Minami H, Imamura Y, et al. Lenvatinib for anaplastic thyroid cancer. Front Oncol. 2017;7:25. https:\/\/doi.org\/10.3389\/fonc.2017.00025.","journal-title":"Front Oncol"},{"key":"995_CR7","doi-asserted-by":"publisher","first-page":"811485","DOI":"10.3389\/fimmu.2021.811485","volume":"12","author":"Z Lamplugh","year":"2021","unstructured":"Lamplugh Z, Fan Y. Vascular microenvironment, tumor immunity and immunotherapy. Front Immunol. 2021;12:811485. https:\/\/doi.org\/10.3389\/fimmu.2021.811485.","journal-title":"Front Immunol"},{"key":"995_CR8","doi-asserted-by":"publisher","first-page":"937344","DOI":"10.3389\/fimmu.2022.937344","volume":"13","author":"Y Han","year":"2022","unstructured":"Han Y, Sun J, Wei H, Hao J, Liu W, Wang X. Ultrasound-Targeted microbubble destruction: modulation in the tumor microenvironment and application in tumor immunotherapy. Front Immunol. 2022;13:937344. https:\/\/doi.org\/10.3389\/fimmu.2022.937344.","journal-title":"Front Immunol"},{"key":"995_CR9","doi-asserted-by":"publisher","unstructured":"Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan T, Yan Y, Tran TM, et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest. 2023;133(11). https:\/\/doi.org\/10.1172\/jci169653.","DOI":"10.1172\/jci169653"},{"issue":"8","key":"995_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1089\/thy.2020.0296","volume":"31","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo M, Williams MD, Ferrarotto R, et al. Clinical utility of circulating cell-free DNA mutations in anaplastic thyroid carcinoma. Thyroid. 2021;31(8):1235\u201343. https:\/\/doi.org\/10.1089\/thy.2020.0296.","journal-title":"Thyroid"},{"key":"995_CR11","doi-asserted-by":"publisher","unstructured":"Sharma D, Leong KX, Czarnota GJ. Application of ultrasound combined with microbubbles for cancer therapy. Int J Mol Sci. 2022;23(8). https:\/\/doi.org\/10.3390\/ijms23084393.","DOI":"10.3390\/ijms23084393"},{"issue":"5","key":"995_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41416-022-02076-y","volume":"128","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang Y, Liu Y, Wang W, Gao S, Yuan W, Sun Z, Liu L, Wang C. Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect. Br J Cancer. 2023;128(5):715\u201325. https:\/\/doi.org\/10.1038\/s41416-022-02076-y.","journal-title":"Br J Cancer"},{"issue":"2","key":"995_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ultrasmedbio.2018.10.002","volume":"45","author":"S Bulner","year":"2019","unstructured":"Bulner S, Prodeus A, Gariepy J, Hynynen K, Goertz DE. Enhancing checkpoint inhibitor therapy with ultrasound stimulated microbubbles. Ultrasound Med Biol. 2019;45(2):500\u201312. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2018.10.002.","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"995_CR14","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2023.5.Focus23227","volume":"55","author":"G Grasso","year":"2023","unstructured":"Grasso G, Torregrossa F, Noto M, Bruno E, Feraco P, Buscemi F, Bartolotta TV, Gagliardo C. MR-guided focused ultrasound-induced blood-brain barrier opening for brain metastasis: a review. Neurosurg Focus. 2023;55(2):E11. https:\/\/doi.org\/10.3171\/2023.5.Focus23227.","journal-title":"Neurosurg Focus"},{"issue":"6","key":"995_CR15","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1109\/tbme.2021.3130164","volume":"69","author":"B Cheng","year":"2022","unstructured":"Cheng B, Bing C, Chu TH, Alzahrani S, Pichardo S, Pike GB. Simultaneous localized brain mild hyperthermia and blood-brain barrier opening via feedback-controlled transcranial MR-Guided focused ultrasound and microbubbles. IEEE Trans Biomed Eng. 2022;69(6):1880\u20138. https:\/\/doi.org\/10.1109\/tbme.2021.3130164.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"5","key":"995_CR16","doi-asserted-by":"publisher","first-page":"e1004408","DOI":"10.1371\/journal.pmed.1004408","volume":"21","author":"D Moore-Palhares","year":"2024","unstructured":"Moore-Palhares D, Dasgupta A, Saifuddin M, Anzola Pena ML, Prasla S, Ho L, Lu L, Kung J, McNabb E, Sannachi L, et al. Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: a phase 1 clinical trial. PLoS Med. 2024;21(5):e1004408. https:\/\/doi.org\/10.1371\/journal.pmed.1004408.","journal-title":"PLoS Med"},{"key":"995_CR17","doi-asserted-by":"publisher","first-page":"110380","DOI":"10.1016\/j.radonc.2024.110380","volume":"198","author":"D Moore-Palhares","year":"2024","unstructured":"Moore-Palhares D, Saifuddin M, Dasgupta A, Anzola Pena ML, Prasla S, Ho L, Lu L, Kung J, Karam I, Poon I, et al. Radiation enhancement using focussed ultrasound-stimulated microbubbles for head and neck cancer: a phase 1 clinical trial. Radiother Oncol. 2024;198:110380. https:\/\/doi.org\/10.1016\/j.radonc.2024.110380.","journal-title":"Radiother Oncol"},{"key":"995_CR18","doi-asserted-by":"publisher","unstructured":"Jahangiri S, Yu F. Fundamentals and applications of focused Ultrasound-Assisted cancer immune checkpoint Inhibition for solid tumors. Pharmaceutics. 2024;16(3). https:\/\/doi.org\/10.3390\/pharmaceutics16030411.","DOI":"10.3390\/pharmaceutics16030411"},{"key":"995_CR19","doi-asserted-by":"publisher","unstructured":"Almasri F, Sakarya EH, Karshafian R. Radioenhancement with the combination of docetaxel and ultrasound microbubbles: in vivo prostate cancer. Pharmaceutics. 2023;15(5). https:\/\/doi.org\/10.3390\/pharmaceutics15051468.","DOI":"10.3390\/pharmaceutics15051468"},{"key":"995_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2020.10.046","volume":"498","author":"N Li","year":"2021","unstructured":"Li N, Tang J, Yang J, Zhu B, Wang X, Luo Y, Yang H, Jang F, Zou J, Liu Z, et al. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 Blockade of MC38 colon cancer in mice. Cancer Lett. 2021;498:121\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.046.","journal-title":"Cancer Lett"},{"issue":"1","key":"995_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12951-024-02437-0","volume":"22","author":"M Du","year":"2024","unstructured":"Du M, Wang T, Peng W, Feng R, Goh M, Chen Z. Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced Immunogenic cell death. J Nanobiotechnol. 2024;22(1):167. https:\/\/doi.org\/10.1186\/s12951-024-02437-0.","journal-title":"J Nanobiotechnol"},{"key":"995_CR22","doi-asserted-by":"publisher","unstructured":"Tsai TH, Chen YJ, Wang LY, Hsieh CH. Impact of local liver irradiation concurrent versus sequential with Lenvatinib on pharmacokinetics and biodistribution. Cancers (Basel). 2021;13(7). https:\/\/doi.org\/10.3390\/cancers13071598.","DOI":"10.3390\/cancers13071598"},{"issue":"4","key":"995_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/thy.2006.0246","volume":"17","author":"JJ Lee","year":"2007","unstructured":"Lee JJ, Foukakis T, Hashemi J, Grimelius L, Heldin NE, Wallin G, Rudduck C, Lui WO, H\u00f6\u00f6g A, Larsson C. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models. Thyroid. 2007;17(4):289\u2013301. https:\/\/doi.org\/10.1089\/thy.2006.0246.","journal-title":"Thyroid"},{"issue":"2","key":"995_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12020-019-02009-5","volume":"66","author":"AT Pinto","year":"2019","unstructured":"Pinto AT, Pojo M, Sim\u00f5es-Pereira J, Roque R, Saramago A, Roque L, Martins C, Andr\u00e9 S, Cabe\u00e7adas J, Leite V, et al. Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology. Endocrine. 2019;66(2):288\u2013300. https:\/\/doi.org\/10.1007\/s12020-019-02009-5.","journal-title":"Endocrine"},{"issue":"10","key":"995_CR25","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.Ccr-18-2953","volume":"25","author":"I Landa","year":"2019","unstructured":"Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, et al. Comprehensive genetic characterization of human thyroid cancer cell lines: A validated panel for preclinical studies. Clin Cancer Res. 2019;25(10):3141\u201351. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2953.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"995_CR26","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/jc.2008-1102","volume":"93","author":"RE Schweppe","year":"2008","unstructured":"Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93(11):4331\u201341. https:\/\/doi.org\/10.1210\/jc.2008-1102.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"995_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.21873\/cdp.10194","volume":"3","author":"V Papanikolaou","year":"2023","unstructured":"Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, et al. Anti-EGFR\/BRAF-Tyrosine kinase inhibitors in thyroid carcinoma. Cancer Diagn Progn. 2023;3(2):151\u20136. https:\/\/doi.org\/10.21873\/cdp.10194.","journal-title":"Cancer Diagn Progn"},{"issue":"4","key":"995_CR28","first-page":"1457","volume":"13","author":"L Xue","year":"2023","unstructured":"Xue L, Gong Z, Vlantis AC, Chan JY, Meehan K, van Hasselt CA, Li D, Zeng X, Wei M, Tong MC, et al. Autophagy regulates anti-angiogenic property of Lenvatinib in thyroid cancer. Am J Cancer Res. 2023;13(4):1457\u201370.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"995_CR29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/jcb.30344","volume":"123","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Nawaz MI. Molecular mechanism of VEGF and its role in pathological angiogenesis. J Cell Biochem. 2022;123(12):1938\u201365. https:\/\/doi.org\/10.1002\/jcb.30344.","journal-title":"J Cell Biochem"},{"issue":"19","key":"995_CR30","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358(19):2039\u201349. https:\/\/doi.org\/10.1056\/NEJMra0706596.","journal-title":"N Engl J Med"},{"key":"995_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2022.06.044","volume":"173","author":"T Higashiyama","year":"2022","unstructured":"Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, et al. Phase II study of the efficacy and safety of Lenvatinib for anaplastic thyroid cancer (HOPE). Eur J Cancer. 2022;173:210\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2022.06.044.","journal-title":"Eur J Cancer"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00995-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00995-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00995-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:06:26Z","timestamp":1761300386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00995-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00995-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"type":"electronic","value":"2050-6511"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Care and Use Committee of Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine had permitted the study. All animal experiments and euthanization protocol were performed in line with the Animal Study Guidelines of Affiliated Hospital of Integrated Traditional Chinese and Western Medicine (AEWC-20230308-270) and the ARRIVE guidelines, Nanjing University of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}